Blog

Introduction: FDA Draft Guidance “Labeling for Biosimilar and Interchangeable Biosimilar Products”

Beers List Drug on Medicare Negotiated Price List

Who Assigns Labeler Codes?

Medical Devices and Digital Therapeutics: Many Ways to Get to Market

New FDA Guidance on the Test-to-Treat COVID-19 Anti-Virals

Pharmacist Shortages

Digital Therapeutics & Updates on Payer Coverage

FDA Approves OTC Naloxone

Impacts of the End of COVID-19 Public Health Emergency on PBMs/Payers

Brown Bagging, White Bagging, and Clear Bagging: What it Means and How it Works